Net profit of Sandu Pharmaceuticals rose 29.41% to Rs 0.22 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. Sales declined 2.05% to Rs 16.70 crore in the quarter ended June 2025 as against Rs 17.05 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 16.70 | 17.05 | -2 |
| OPM % | 3.17 | 2.46 | - |
| PBDT | 0.52 | 0.44 | 18 |
| PBT | 0.34 | 0.28 | 21 |
| NP | 0.22 | 0.17 | 29 |